AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Is the FDA Too Cautious?
Open to Debate
The FDA's Response to Pressure
Peter Lorry and Colin Hill: Is the FDA too cautious? John Donven: I think that you perhaps misunderstand the way the FDA does experience pressure. Most of the time when a drug kills people, take Vioxx, for example, right? And if you take it to court on that basis, you are not going to win your malpractice or product liability case. In Congress, the pressure is not on the safety side anymore. It's on the business-friendly efficacy side. That's what the agency's responded to.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode